Investigator initiated: Conventional prophylactic regimen of oral dexamethasone versus short-course intravenous dexamethasone in preventing paclitaxel-related hypersensitivity reactions in breast and gynecologic-oncology patients: A prospective, randomized, open-label study,
Role: Investigator,
LLU Dept. of Gynecology & Obstetrics,
(02/2024 - 01/2025)
Status: Completed
Bicalutamide plus leuprolide versus degarelix plus leuprolide as androgen deprivation therapy for patients with advanced or metastatic prostate cancer: A retrospective cohort study assessing incidence of tumor flare and cost-differences between each regimen,
Role: PI,
LLU Dept. of Pharmacy Practice,
(11/2022 - 01/2024)
Status: Completed
Investigator Initiated: A Retrospective chart review of patients treated with immune checkpoint inhibitors (ICI) to evaluate severe and fatal adverse events in the emergency department,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(07/2021 - 10/2024)
Status: Completed
Investigator Initiated: The bone-targeting agents and the need for electrolyte monitoring in cancer patients: A retrospective cohort study of cancer patients treated between January 1,2014 to June 24, 2020,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(07/2020 - 09/2024)
Status: Completed
Effects of chemotherapy on the concentration of minerals in hair,
Role: Investigator,
LLU Dept. of Allied Health Studies,
(07/2019)
Status: Completed
Risk Factors of Hypomagnesemia in Patients with Bone Metastases from Solid Malignancies Treated with Zoledronic Acid: A Single-institution Retrospective Study,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(10/2024)
Status: Approved
Cost analysis of subcutaneous daratumumab compared to intravenous daratumumab in multiple myeloma patients: A retrospective chart review,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(11/2024)
Status: Approved